Statistics for BIPSE: A Biomarker-based Phase I/II Design for Immunotherapy Trials with Progression-free Survival Endpoint

Total visits

views
BIPSE: A Biomarker-based Phase I/II Design for Immunotherapy Trials with Progression-free Survival Endpoint 5

Total visits per month

views
May 2024 0
June 2024 1
July 2024 0
August 2024 0
September 2024 0
October 2024 0
November 2024 0

File Visits

views
nihms-1823068.pdf 12

Top country views

views
United States 4
India 1

Top city views

views
Greenwood 3
Ashburn 1